# Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

> **NCT04343209** · — · COMPLETED · sponsor: **Ionetix Corporation** · enrollment: 170 (actual)

## Conditions studied

- Myocardial Ischemia
- Coronary Disease
- Coronary Artery Disease
- Heart Diseases
- Cardiovascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Vascular Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Myocardial Perfusion Imaging Study
- **DRUG:** AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]

## Key facts

- **NCT ID:** NCT04343209
- **Lead sponsor:** Ionetix Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-14
- **Primary completion:** 2024-08-16
- **Final completion:** 2024-08-16
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2024-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04343209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04343209, "Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04343209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*